Medicure (MCUJF) Stock Price, News & Analysis

Company Overview

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors. Its commercial portfolio includes branded cardiovascular products, while its research and development pipeline features small‐molecule candidates targeting acute heart failure, pulmonary hypertension and related conditions. The company leverages its regulatory and clinical expertise to shepherd assets from late‐stage development through to market access.

Since its founding in 2004, Medicure has grown by forging collaborations with both larger pharmaceutical companies and specialty distributors, aiming to accelerate product launches and maximize reach in key therapeutic segments. The senior leadership team brings decades of experience in drug development, regulatory affairs and commercial operations, positioning Medicure to advance its niche cardiovascular and critical‐care medicines to patients in need.

Key Stats

• Today's Range: $0.78 to $0.78
• 50-Day Range: $0.71 to $0.94
• 52-Week Range: $0.44 to $0.94
• Volume: N/A
• Average Volume: 972 shs
• Market Capitalization: $8.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MCUJF Stock Analysis - Frequently Asked Questions

How have MCUJF shares performed this year?

Medicure's stock was trading at $0.62 at the beginning of 2025. Since then, MCUJF shares have increased by 25.5% and is now trading at $0.7780.

How were Medicure's earnings last quarter?

Medicure Inc. (OTCMKTS:MCUJF) posted its quarterly earnings results on Wednesday, August, 20th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm earned $4.82 million during the quarter. Medicure had a negative net margin of 5.70% and a negative trailing twelve-month return on equity of 6.65%.

How do I buy shares of Medicure?

Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/20/2025
• Today: 10/18/2025
• Next Earnings (Estimated): 11/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MCUJF
• CIK: 1133519
• Web: www.medicure.com
• Phone: (204) 487-7412
• Fax: 204-488-9823
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$760 thousand
• Net Margins: -5.70%
• Pretax Margin: -4.85%
• Return on Equity: -6.65%
• Return on Assets: -4.52%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.48
• Quick Ratio: 1.06

Sales & Book Value

• Annual Sales: $15.99 million
• Price / Sales: 0.51
• Cash Flow: $0.09 per share
• Price / Cash Flow: 8.72
• Book Value: $1.45 per share
• Price / Book: 0.54

Miscellaneous

• Outstanding Shares: 10,440,000
• Free Float: 9,090,000
• Market Cap: $8.12 million
• Optionable: Not Optionable
• Beta: 1.05